Geopolitics Alpha

NovoCure Limited 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NVCR) 2026-10-31

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHANovoCure Limited 2026 Q3 - Results- Earnings Call Presentation(NASDAQ:NVCR) 2026-10-31NVCRGEOPOLITICS ALPHA

This report is about the broad US market.

Directly affected

  • NVCR NovoCure-10.7% 11d

    Named in this report.

Indirectly affected

  • DIA SPDR Dow Jones Industrial Average ETF+0.3% 13d

    SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “nasdaq” (the broad US market) in this story.

  • QQQ Invesco QQQ-9.8% 30d

    Invesco QQQ: it is a broad US stock-market fund. Linked by “nasdaq” (the broad US market) in this story.

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that NovoCure belongs to, so it often moves with news about it.

  • SYK Stryker+16.7% 30d

    Stryker is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MMM 3M+15.1% 30d

    3M is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BSX Boston Scientific+3.8% 30d

    Boston Scientific is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BDX Becton, Dickinson and+19.7% 30d

    Becton, Dickinson and is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MDLN Medline+9.3% 30d

    Medline is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
NVCR+9.63%+7.65%base+0.42%+2.40%+11.19%+3.16%
DIA+1.17%+1.48%base+0.44%+0.00%+3.10%-0.47%
QQQ+3.12%+5.08%base-1.30%-0.76%+0.17%-5.59%
XLV-3.03%-2.77%base-0.14%-0.48%+2.59%+0.17%
SYK+5.10%+4.38%base+5.34%+6.53%+16.59%+14.97%
MMM-0.88%-0.89%base+2.34%+1.58%+11.32%+7.71%
BSX+8.65%+1.02%base+5.62%+3.65%+9.15%+6.31%
BDX-0.73%-1.34%base+0.39%+0.20%+5.67%+7.90%
MDLN+4.92%+0.90%base+4.80%+6.26%+25.81%+23.96%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

NovoCure Limited 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NVCR) 2026-10-31 Seeking Alpha

Source: Seeking Alpha

This story

CompanyWhenMoveStatus
BDXthat day+0.39%final price
BDXthe next day+0.20%final price
BDXtwo days later+5.67%final price
BDXthree days later+7.90%final price
BDXthree days earlier-1.34%final price
BDXfive days earlier-0.73%final price
BSXthat day+5.62%final price
BSXthe next day+3.65%final price
BSXtwo days later+9.15%final price
BSXthree days later+6.31%final price
BSXthree days earlier+1.02%final price
BSXfive days earlier+8.65%final price
DIAthat day+0.44%final price
DIAthe next day0.00%final price
DIAtwo days later+3.10%final price
DIAthree days later-0.47%final price
DIAthree days earlier+1.48%final price
DIAfive days earlier+1.17%final price
MDLNthat day+4.80%final price
MDLNthe next day+6.26%final price
MDLNtwo days later+25.81%final price
MDLNthree days later+23.96%final price
MDLNthree days earlier+0.90%final price
MDLNfive days earlier+4.92%final price
MMMthat day+2.34%final price
MMMthe next day+1.58%final price
MMMtwo days later+11.32%final price
MMMthree days later+7.71%final price
MMMthree days earlier-0.89%final price
MMMfive days earlier-0.88%final price
NVCRthat day+0.42%final price
NVCRthe next day+2.40%final price
NVCRtwo days later+11.19%final price
NVCRthree days later+3.16%final price
NVCRthree days earlier+7.65%final price
NVCRfive days earlier+9.63%final price
QQQthat day-1.30%final price
QQQthe next day-0.76%final price
QQQtwo days later+0.17%final price
QQQthree days later-5.59%final price
QQQthree days earlier+5.08%final price
QQQfive days earlier+3.12%final price
SYKthat day+5.34%final price
SYKthe next day+6.53%final price
SYKtwo days later+16.59%final price
SYKthree days later+14.97%final price
SYKthree days earlier+4.38%final price
SYKfive days earlier+5.10%final price
XLVthat day-0.14%final price
XLVthe next day-0.48%final price
XLVtwo days later+2.59%final price
XLVthree days later+0.17%final price
XLVthree days earlier-2.77%final price
XLVfive days earlier-3.03%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“NovoCure Limited 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NVCR) 2026-10-31” scores 12 out of 100. The score uses 1 sources.